from

Flare Therapeutics Presents Part A Data from FX-909 Phase 1 Study at AACR-NCI-EORTC International Conference

October 24, 2025 12:00 ET  | Source: Flare Therapeutics Inc. FX-909, the first small molecule targeting PPARG to be tested…

1 month ago

PMV Pharmaceuticals Announces Updated Rezatapopt Monotherapy Interim Data From Ongoing PYNNACLE Phase 2 Trial Across Multiple Solid Tumors With a TP53 Y220C Mutation

October 24, 2025 11:39 ET  | Source: PMV Pharmaceuticals, Inc. Data presented today as an oral presentation at 2025 AACR-NCI-EORTC…

1 month ago

Switching from Lead-Acid to Lithium Is Easier Than You Think. LiTime’s One-Stop Upgrade Solutions Empower RV, Marine, and Other Users to Go Lithium with Ease

Shenzhen, China , Oct. 23, 2025 (GLOBE NEWSWIRE) -- Have you ever been held back by a lead-acid battery? On an…

1 month ago

Ofirnoflast (HT-6184) Receives Orphan Drug Designation from U.S. FDA for Myelodysplastic Syndromes

LEHI, Utah, Oct. 23, 2025 /PRNewswire/ -- Halia Therapeutics, Inc., a clinical-stage biopharmaceutical company pioneering therapies that target the root causes…

1 month ago

ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors

SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings…

1 month ago

Padma Shri Rajinder Gupta, Emeritus Chairman of Trident Group, Elected Unopposed to Rajya Sabha from Punjab

State of Punjab and Nationally – Textile Sector to immensely benefit from this announcement NEW DELHI and CHANDIGARH, India, Oct.…

1 month ago

LAS VEGAS TO WELCOME DIRECT, NONSTOP SERVICE FROM PARIS ON AIR FRANCE BEGINNING APRIL 15, 2026

Seasonal service to run through October 24, 2026Tickets on sale now at AirFrance.us LAS VEGAS – Air France, the flag…

1 month ago

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response…

2 months ago

CoinLander Launches RWA Platform, Unlocking Stable Returns from Tokenized Real Estate Mortgages

Platform Democratizes Access to Real-World Asset (RWA) Investments, Merging Tangible Security with Blockchain Efficiency ROAD TOWN, British Virgin Islands, Oct.…

2 months ago

From Economic Turbulence to a New Era of Wealth: NB HASH RWA Brings Real-World Assets On-Chain for Stable Digital Growth

London, UK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- As global markets face inflation, currency depreciation, and rising uncertainty, investors are…

2 months ago